单中心腹膜透析相关性腹膜炎患者的致病菌群分布特点及药敏分析
Distribution Characteristics of Pathogens and Antibiotic Sensitivity Analysis in Patients with Peritoneal Dialysis-Associated Peritonitis: A Single-Center Study
摘要: 目的:通过回顾性分析渝西地区腹膜透析相关性腹膜炎(PDAP)的病例资料、一般实验室指标、腹透液培养结果及其药敏分析,为渝西地区PDAP患者制定治疗方案提供理论依据。方法:通过回顾性筛选2016年5月至2024年12月重庆医科大学附属永川医院维持性腹膜透析因PDAP住院的患者,收集患者的腹膜透析液病原学检测结果,分析致病菌群分布特点及药敏分析。结果:共收集腹膜透析液培养结果共211例,其中腹膜透析液培养阳性结果共149例(阳性率70.62%)。腹膜透析液培养阳性结果中,G+菌共88例(59.06%),G+菌中以葡萄球菌为主,共41例。G−菌共54例(36.24%),以大肠埃希菌为主,共13例(8.72%)。真菌6例(4.03%),其中近平滑假丝酵母2例(1.34%)。分枝杆菌1例(0.6%)。G+菌中,葡萄球菌对利奈唑胺、万古霉素普遍敏感;肠球菌、链球菌对利奈唑胺普遍敏感;大多数葡萄球菌对利福平敏感(97.22%)。G−菌中,肠杆菌科对亚胺培南敏感(96.43%)。结论:本中心腹膜透析患者发生腹膜透析相关性腹膜炎致病菌主要为G+菌,其对青霉素及大环内酯类抗生素耐药率较高,对喹诺酮类、碳青霉烯类、万古霉素等药物敏感性较高。G−菌中,肠杆菌科对亚胺培南敏感,对喹诺酮类抗生素耐药性较高。
Abstract: Objective: To provide a theoretical basis for developing treatment protocols for peritoneal dialysis-associated peritonitis (PDAP) patients in western Chongqing through retrospective analysis of case records, general laboratory indicators, dialysate culture results, and antimicrobial susceptibility testing. Methods: Patients hospitalized for PDAP during maintenance peritoneal dialysis at The Affiliated Yongchuan Hospital of Chongqing Medical University from May 2016 to December 2024 were retrospectively screened. Peritoneal dialysate culture results were collected to analyze pathogen distribution characteristics and antimicrobial susceptibility testing. Results: A total of 211 PDL culture results were collected, with 149 positive cultures (70.62% positivity rate). Among positive cultures: Gram-positive bacteria (G+): 88 cases (59.06%), predominantly Staphylococcus (41 cases). G-negative bacteria were identified in 54 cases (36.24%), predominantly Escherichia coli (13 cases, 8.72%). Fungi were detected in 6 cases (4.03%), including 2 cases of Candida parapsilosis (1.34%). Mycobacteria were identified in 1 case (0.6%). Among G+ bacteria, Staphylococcus species exhibited widespread susceptibility to linezolid and vancomycin; Enterococcus and Streptococcus species showed widespread susceptibility to linezolid; most Staphylococcus species were susceptible to rifampin (97.22%). Among Gram-negative bacteria, Enterobacteriaceae exhibited sensitivity to imipenem (96.43%). Conclusion: Pathogens causing PDAP in peritoneal dialysis patients at our center were predominantly Gram-positive bacteria. These exhibited high resistance rates to penicillin and macrolide antibiotics, while maintaining high sensitivity to quinolones, carbapenems, and vancomycin. Among Gram-negative bacteria, Enterobacteriaceae exhibited sensitivity to imipenem but showed high resistance to fluoroquinolones.
文章引用:彭涛, 黎洋. 单中心腹膜透析相关性腹膜炎患者的致病菌群分布特点及药敏分析[J]. 临床医学进展, 2026, 16(5): 14-23. https://doi.org/10.12677/acm.2026.1651784

参考文献

[1] Xie, Y., Bowe, B., Mokdad, A.H., Xian, H., Yan, Y., Li, T., et al. (2018) Analysis of the Global Burden of Disease Study Highlights the Global, Regional, and National Trends of Chronic Kidney Disease Epidemiology from 1990 to 2016. Kidney International, 94, 567-581. [Google Scholar] [CrossRef] [PubMed]
[2] Al Sahlawi, M., Bargman, J.M. and Perl, J. (2020) Peritoneal Dialysis-Associated Peritonitis: Suggestions for Management and Mistakes to Avoid. Kidney Medicine, 2, 467-475. [Google Scholar] [CrossRef] [PubMed]
[3] Szeto, C. and Li, P.K. (2019) Peritoneal Dialysis-Associated Peritonitis. Clinical Journal of the American Society of Nephrology, 14, 1100-1105. [Google Scholar] [CrossRef] [PubMed]
[4] Perl, J., Fuller, D.S., Boudville, N., Kliger, A.S., Schaubel, D.E., Teitelbaum, I., et al. (2020) Optimizing Peritoneal Dialysis-Associated Peritonitis Prevention in the United States: From Standardized Peritoneal Dialysis-Associated Peritonitis Reporting and Beyond. Clinical Journal of the American Society of Nephrology, 16, 154-161. [Google Scholar] [CrossRef] [PubMed]
[5] Chung, M., Yu, T., Wu, M., Chuang, Y., Muo, C., Chen, C., et al. (2022) Impact of Peritoneal Dialysis-Related Peritonitis on PD Discontinuation and Mortality: A Population-Based National Cohort Study. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 42, 194-203. [Google Scholar] [CrossRef] [PubMed]
[6] Domingues, P., Furtado, T., Valério, P., Matias, J. and Cunha, L. (2023) Under-Recognized Pathogens in Peritoneal Dialysis Associated-Peritonitis: The Importance of Early Detection. Cureus, 15, e35445. [Google Scholar] [CrossRef] [PubMed]
[7] Muthucumarana, K., Howson, P., Crawford, D., Burrows, S., Swaminathan, R. and Irish, A. (2016) The Relationship between Presentation and the Time of Initial Administration of Antibiotics with Outcomes of Peritonitis in Peritoneal Dialysis Patients: The PROMPT Study. Kidney International Reports, 1, 65-72. [Google Scholar] [CrossRef] [PubMed]
[8] You, L., Zhang, B., Zhang, F. and Wang, J. (2024) Pathogenic Spectrum and Risk Factors of Peritoneal Dialysis-Associated Peritonitis: A Single-Center Retrospective Study. BMC Infectious Diseases, 24, Article No. 440. [Google Scholar] [CrossRef] [PubMed]
[9] Li, P.K., Chow, K.M., Cho, Y., Fan, S., Figueiredo, A.E., Harris, T., et al. (2022) ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 42, 110-153. [Google Scholar] [CrossRef] [PubMed]
[10] Goffin, E. (2008) Peritoneal Membrane Structural and Functional Changes during Peritoneal Dialysis. Seminars in Dialysis, 21, 258-265. [Google Scholar] [CrossRef] [PubMed]
[11] Cho, Y., Htay, H. and Johnson, D.W. (2017) Centre Effects and Peritoneal Dialysis-Related Peritonitis. Nephrology Dialysis Transplantation, 32, 913-915. [Google Scholar] [CrossRef] [PubMed]
[12] 邹燕, 吴宪鸣, 徐兰, 等. 腹膜透析相关性腹膜炎腹水病原学分布特点及危险因素分析[J]. 山西卫生健康职业学院学报, 2021, 31(6): 73-74.
[13] 张谊, 周刚, 高波, 等. 中国江苏省扬州市单中心腹膜透析相关性腹膜炎致病菌谱与药敏分析[J]. 中国中西医结合肾病杂志, 2023, 24(7): 616-620.
[14] 杨滨鸿, 王秀芬, 张涛, 等. 多重耐药菌腹膜透析相关性腹膜炎的临床特征和转归分析[J]. 中国血液净化, 2023, 22(12): 900-904.
[15] Hu, S., Tong, R., Bo, Y., Ming, P. and Yang, H. (2019) Fungal Peritonitis in Peritoneal Dialysis: 5-Year Review from a North China Center. Infection, 47, 35-43. [Google Scholar] [CrossRef] [PubMed]
[16] Akoh, J.A. (2012) Peritoneal Dialysis Associated Infections: An Update on Diagnosis and Management. World Journal of Nephrology, 1, 106-122. [Google Scholar] [CrossRef] [PubMed]
[17] 杨国凯, 洪富源, 吴家斌, 等. 口服氟康唑对细菌性腹膜炎腹膜透析患者继发真菌性腹膜炎的影响[J]. 中华医院感染学杂志, 2014, 24(17): 4290-4291, 4297.
[18] Guo, S., Fu, G., Hu, Y., Liu, J. and Wang, Y. (2024) Application of Metagenomic Next-Generation Sequencing Technology in the Etiological Diagnosis of Peritoneal Dialysis-Associated Peritonitis. Open Life Sciences, 19, Article ID: 20220865. [Google Scholar] [CrossRef] [PubMed]